|
Michal Fried, Ph.D.
Mission
Dr. Fried and her colleagues study the
development of vaccines against malaria and
work to identify disease biomarkers.
Research
Together with the laboratory of Dr. Patrick
Duffy, Dr. Fried’s lab made the seminal
finding that pregnant women are infected by
parasites that bind to the placental
receptor chondriotin sulfate A, and
antibodies that inhibit parasite adhesion to chondroin sulfate A confer protection. These
studies form the basis of the current effort
to develop a pregnancy malaria vaccine.
About half of the women with placental
malaria (PM) do not have parasites detected
in peripheral blood smears. PM is associated
with poor outcomes for both the mother and
her baby, commonly in the form of maternal
anemia and low birth weight deliveries.
Biomarkers for malaria disease and immunity
do not exist for most malaria syndromes.
Biomarkers of infection in pregnant women
are required to evaluate the efficacy of
interventions such as vaccines and
chemotherapy. One of the differences between
malaria infection in non-immune and immune
women is in the parasite density in the
placenta. High parasite densities commonly
occur in placentas from non-immune women, as
well as inflammatory immune responses,
including massive inflammatory infiltrates
in the placenta. Using a combination of host
and pathogen biomarkers may allow us to
detect infection or to predict poor
outcomes. Proteomics tools are used to
compare plasma proteome profiles between
protected and unprotected women to identify
disease biomarkers.
Themes
* Parasite
adhesion
* Pregnancy
malaria vaccines
* Malaria
biomarkers
|
Accomplishments |
| * |
Described the molecular basis of
placental malaria |
| * |
Described the association between
anti-adhesion antibodies and protective immunity |
| * |
Utilized proteomics tools to identify
vaccine candidates |
|
* |
Established pregnancy malaria biomarkers
study |
Collaborations
* Pacific
Northwest National Laboratory
* MOMS
Project, Morogoro, Tanzania
* Sokoine
University, Morogoro, Tanzania
Dr. Fried’s research is currently supported by the National Institutes of Health (NIH),
the Bill & Melinda Gates Foundation, and the
Grand Challenges for Global Health.
|